Interactive Digital Media (IDM) Biomedical Science Resources for Pre-College Students and Teachers (SBIR) (R43/R44 Clinical Trial Not Allowed)
ID: 348737Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Award Range

$0 - $296K

Eligible Applicants

Small Businesses

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/348737

Additional Information

http://grants.nih.gov/grants/guide/pa-files/PAR-23-213.html
Timeline
    Description

    The National Institutes of Health (NIH) has announced a funding opportunity aimed at supporting small business concerns (SBCs) in the development of interactive digital media (IDM) biomedical science resources for pre-college students and teachers. This initiative, part of the Small Business Innovation Research (SBIR) program, seeks innovative projects that enhance engagement in biomedical science education, focusing on cultural and age appropriateness, accessibility, and real-time student assessments. Eligible applicants, primarily U.S.-based SBCs, can apply for grants with a budget ceiling of approximately $295,924 for Phase I and $1,972,828 for Phase II, with key deadlines including a close date of September 5, 2025. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov or visit the additional information link at https://grants.nih.gov/grants/guide/pa-files/PAR-23-213.html.

    Point(s) of Contact
    grantsinfo@nih.gov
    Files
    Title
    Posted
    PAR-23-213-Full-Announcement.html
    PAR-23-213.html
    The Department of Health and Human Services, through the National Institutes of Health (NIH), has released a Notice of Funding Opportunity (NOFO) aimed at supporting small business concerns (SBCs) in developing interactive digital media (IDM) resources for pre-college students and teachers. This initiative, under the SBIR program, specifically seeks innovative projects that enhance engagement in biomedical science education, emphasizing cultural and age appropriateness, accessibility, and real-time student assessments. Applicants must meet eligibility requirements, including being U.S.-based and primarily U.S.-operating SBCs, and can apply for Phase I, Phase II, or Fast-Track grants, with budgets capped at approximately $295,924 for Phase I and $1,972,828 for Phase II. Key application dates commence from September 2023, with grant periods limited to six months for Phase I and two years for Phase II. The review process will assess scientific and technical merit, with particular emphasis on significance, innovation, approach, and potential educational impact. Funding decisions will consider relevance to program priorities and compliance with federal policies regarding foreign affiliations and national security. This NOFO exemplifies efforts to foster advanced educational tools within the STEM fields through innovative digital platforms.
    Similar Opportunities
    NIH and CDC Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH), in collaboration with the Centers for Disease Control and Prevention (CDC), is offering a Small Business Innovation Research (SBIR) Grant opportunity for United States small business concerns (SBCs) to submit applications for various phases of research and development, including Phase I, Phase II, Direct to Phase II, Fast-Track, and Phase IIB grants. Eligible applicants must possess the necessary research capabilities and technological expertise to support the R&D missions of the NIH and CDC, with a focus on health-related innovations. This funding opportunity is significant as it encourages collaboration among small businesses to advance health research, with applications expected to be solicited following the reauthorization of the SBIR program. Interested parties can reach out to the NIH SEED Office at SEEDinfo@nih.gov or call 301-827-8595 for further information, with the estimated synopsis posting date set for October 1, 2025, and a closing date for applications anticipated on January 5, 2026.
    NINDS Exploratory Clinical Trials for Small Business (R41/R42 Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "NINDS Exploratory Clinical Trials for Small Business (R41/R42 Clinical Trial Required)" aimed at supporting Small Business Concerns (SBCs) in conducting investigator-initiated exploratory clinical trials related to neurological disorders. This initiative encourages applications for Phase I and II studies focusing on drugs, biologics, devices, and therapies that align with the mission of the National Institute of Neurological Disorders and Stroke (NINDS), emphasizing the inclusion of a Plan for Enhancing Diverse Perspectives (PEDP) to foster innovation. The maximum funding amounts are $295,924 for Phase I and $1,972,828 for Phase II projects, with applications required to demonstrate readiness for eventual FDA regulatory approval. Interested applicants can begin submitting proposals on December 5, 2023, with the application deadline set for September 5, 2026; for further inquiries, contact NIH Grants Information at grantsinfo@nih.gov.
    NINDS Exploratory Clinical Trials for Small Business (R43/R44 Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity for small business concerns (SBCs) through the NINDS Exploratory Clinical Trials program (R43/R44), aimed at supporting investigator-initiated exploratory clinical trials related to neurological disorders. This program invites applications for studies that evaluate drugs, biologics, devices, or therapies, generating preliminary data to inform future clinical development, with a focus on enhancing diverse perspectives within research teams. Eligible U.S.-based SBCs can apply for funding caps of up to $295,924 for Phase I and $1,972,828 for Phase II, with applications due by September 5, 2026. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov or visit the additional information link at https://grants.nih.gov/grants/guide/pa-files/PAR-23-311.html.
    NIH Science Education Partnership Award (SEPA)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Science Education Partnership Award (SEPA) grant to support innovative educational activities aimed at encouraging pre-college students, from pre-kindergarten to grade 12, to pursue studies in science, technology, engineering, and mathematics (STEM), particularly in biomedical and behavioral sciences. This grant will fund classroom-based projects as well as informal science education initiatives conducted in venues such as after-school programs and libraries, with a strong emphasis on projects that enhance quantitative and computational skills. The estimated award date is April 1, 2027, with applications due by July 7, 2026. For further inquiries, interested applicants can contact Jessica Faupel-Badger at badgerje@nih.gov or by phone at 301-594-0000.
    NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH), in collaboration with the Centers for Disease Control (CDC) and the Food and Drug Administration (FDA), is inviting eligible United States small business concerns (SBCs) to prepare for the upcoming Small Business Innovation Research (SBIR) Grant opportunity, specifically under the Parent SBIR [R43/R44] Clinical Trial Not Allowed category. This funding opportunity aims to support innovative research and development projects that align with the missions of the NIH, CDC, and FDA, encouraging collaborations among small businesses with relevant technological expertise. While applications are not currently being solicited, potential applicants should note that the estimated synopsis post date is October 1, 2025, with a closing date of January 5, 2026, and an estimated award date of June 1, 2026. For further inquiries, interested parties can contact the NIH SEED Office at SEEDinfo@nih.gov or by phone at 301-827-8595.
    Notice of Intent to Publish a Funding Opportunity Announcement for Impact of Technology and Digital Media Exposure Usage on Child and Adolescent Development
    National Institutes of Health
    The National Institutes of Health (NIH) is preparing to publish a Notice of Funding Opportunity (NOFO) aimed at researching the impact of technology and digital media exposure on child and adolescent development. This initiative seeks to address the urgent need for understanding how various forms of technology and digital media, such as social media, video games, and artificial intelligence, affect children's health and development, as well as their interactions with family and peers. With an estimated total program funding of $3 million, the NIH encourages small businesses and collaborative teams with expertise in relevant fields to prepare for this opportunity, although applications are not currently being solicited. Interested parties can reach out to Brett Miller, Ph.D., at brett.miller@nih.gov or by phone at 301-496-9849 for further information, with the anticipated synopsis posting date set for March 1, 2026, and a projected award date of April 1, 2027.
    NIGMS National and Regional Resources
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a federal grant opportunity titled "NIGMS National and Regional Resources," aimed at supporting resources that enhance biomedical research capabilities for a large number of investigators. This program seeks to provide access to state-of-the-art technologies and expertise, enabling substantial numbers of researchers to benefit from resources that may not be available at individual institutions. The grant is open to small businesses, with no cost-sharing or matching requirements, and is categorized under discretionary funding with an estimated award date of June 1, 2026. Interested applicants can reach out to Han Nguyen, Ph.D., at han.nguyen@nih.gov or call 301-594-4640 for further information, and should note that the application period will close on September 25, 2025.
    NINDS Renewal Awards of SBIR Phase II Grants (Phase IIB) for Pre-Clinical Research (R44 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NINDS Renewal Awards of SBIR Phase II Grants (Phase IIB) to support pre-clinical research aimed at bridging funding gaps that impede the commercialization of medical biotechnology products. This funding opportunity specifically targets previously funded SBIR or STTR Phase II projects, with the objective of advancing products or technologies that require federal regulatory approval, while fostering partnerships between small businesses and external investors to enhance commercialization prospects. Applicants are encouraged to secure independent third-party funding that equals or exceeds one-third of the requested NINDS funds, and must include a Plan for Enhancing Diverse Perspectives (PEDP) to promote inclusivity in the research environment. The application deadline is April 5, 2027, and interested parties can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries. More details can be found in the full announcement at https://grants.nih.gov/grants/guide/pa-files/PAR-24-222.html.
    NeuroNEXT Small Business Innovation in Clinical Trials (U44 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "NeuroNEXT Small Business Innovation in Clinical Trials," aimed at encouraging small businesses to conduct exploratory clinical trials of investigational agents related to neurological disorders. This initiative seeks applications for Phase II Small Business Innovation Research (SBIR) projects, with a budget of up to $3 million over five years, focusing on trials that align with the strategic plan of the National Institute of Neurological Disorders and Stroke (NINDS). The program is designed to foster public-private partnerships to enhance the development and commercialization of innovative therapies, ultimately improving clinical outcomes in neuroscience research. Interested applicants must adhere to a Community Engagement and Research Inclusion (CERI) plan, with the first application deadline set for January 5, 2025, and additional deadlines throughout 2026 and 2027. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    Novel Experiential Technologies Assisting Individual Learning (NExT AI) Hubs
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a federal grant opportunity titled "Novel Experiential Technologies Assisting Individual Learning (NExT AI) Hubs," aimed at advancing research on the impact of Artificial Intelligence (AI) technologies on developmental outcomes in children at risk for specific learning disabilities. This initiative, led by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), seeks small businesses to establish Centers that will explore innovative and high-risk research topics related to learning disabilities in reading, writing, and mathematics. The grant does not require cost-sharing or matching and is categorized under health funding activities, with an estimated award date of December 1, 2026. Interested applicants can reach out to Dr. Virginia Salo at virginia.salo@nih.gov or call 301-402-3682 for further information, with proposals due by June 4, 2026.